Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Gynecologic Oncology
|
January 24, 2025
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258
Aine Clements, Danielle Enserro, Kyle C Strickland, et al.
Circulation. Heart Failure
|
June 9, 2016
Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes
Jennifer E Ho, Danielle Enserro, Frank P Brouwers, et al.
The New England Journal of Medicine
|
November 14, 2019
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
Robert L Coleman, Nick M Spirtos, Danielle Enserro, et al.
Gynecologic Oncology
|
November 7, 2020
Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers
Sandra Russo, Joan L Walker, Jay W Carlson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2019
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
Krishnansu S Tewari, Robert A Burger, Danielle Enserro, et al.
JAMA Cardiology
|
January 12, 2018
Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction
Rudolf A de Boer, Matthew Nayor, Christopher R deFilippi, et al.
European Journal of Heart Failure
|
December 12, 2017
Predictors and outcomes of heart failure with mid-range ejection fraction
Vijeta Bhambhani, Jorge R Kizer, Joao A C Lima, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Gynecologic Oncology
|
January 24, 2025
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258
Aine Clements, Danielle Enserro, Kyle C Strickland, et al.
Circulation. Heart Failure
|
June 9, 2016
Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes
Jennifer E Ho, Danielle Enserro, Frank P Brouwers, et al.
The New England Journal of Medicine
|
November 14, 2019
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
Robert L Coleman, Nick M Spirtos, Danielle Enserro, et al.
Gynecologic Oncology
|
November 7, 2020
Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers
Sandra Russo, Joan L Walker, Jay W Carlson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2019
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
Krishnansu S Tewari, Robert A Burger, Danielle Enserro, et al.
JAMA Cardiology
|
January 12, 2018
Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction
Rudolf A de Boer, Matthew Nayor, Christopher R deFilippi, et al.
European Journal of Heart Failure
|
December 12, 2017
Predictors and outcomes of heart failure with mid-range ejection fraction
Vijeta Bhambhani, Jorge R Kizer, Joao A C Lima, et al.
Page
of 3